Since tumors are preferentially enriched in extracellular matrix metalloproteinase (MMP) activity (Fig. 1i)47, ACPP tumor targeting is achieved by inserting a MMP-2/9 sensitive PLGC(Me)AG peptide between the two charged domains of ACPP (Fig. 1h)48. The gene discussed is MMP2; the disease is neoplasm.